Results for:

Sanofi board to meet Tuesday after sacking CEO - sources

Sanofi draws up candidate shortlist for top job - source

Sanofi touts new drugs but diabetes outlook disappoints

L'Oreal CEO says ready to buy out Nestle stake in 2014: paper

Sanofi bets on inhaled insulin with up to $925 million MannKind deal

Sanofi bets on inhaled insulin with MannKind deal

Big Pharma stands to profit by cleaning out its medicine chests

Euro's slide revives hopes of European corporate profits recovery

J&ampJ hunts for dengue fever drugs in tie-up with academia

US clears AstraZeneca over heart drug trial

Analysis - Plant-based vaccines challenge big pharma for $3 billion flu...

Sanofi says told U.S. about bribery claims in Africa, Mideast

Senior JPMorgan deal maker Elliott to retire in June

Merck explores $15 billion-plus drug portfolio sale - sources

L'Oreal could sell Sanofi stake to fund acquisitions: CEO

Exclusive - Sanofi explores $7 billion-plus sale of drug portfolio: sources

Drugmakers look to push the boundaries of old age

Drugmaker GSK to invest 130 million pounds in African factories, R&ampD

Plant-based vaccines challenge big pharma for $3 billion flu market

Shares rise as investors put faith in Fed's message

Power of 'France Inc' on display in Sanofi boardroom coup

Eli Lilly says 'deeply concerned' by bribery allegations in China

Pfizer may have to pay more cash and top $105 billion to win AstraZeneca

Sanofi board ousts CEO Viehbacher, Chairman Weinberg takes helm

Morgan Stanley calls Valeant 'house of cards' in Allergan pitch

Desmarest quits Sanofi board to focus on Total role

Actavis, Sanofi among bidders for Omega Pharma- Bloomberg

Sanofi to stick to bolt-on deals amid pharma M&ampA buzz

L'Oreal says has means to buy Nestle's stake

Novartis employee pleaded guilty in Polish bribery case

Eli Lilly copy of $8 billion Sanofi insulin wins EU green light

Sanofi held talks with Abbott, Mylan about mature drugs - document

U.S. clears AstraZeneca over heart drug trial

Analysis - Fate of $23 billion L'Oreal stake points to future of Nestle

Sanofi shares sink as diabetes sales slow, CEO pressured

How the wheels came off for Sanofi's CEO